109 related articles for article (PubMed ID: 30921714)
1. A spatial study of bladder cancer mortality and incidence in the contiguous US: 2000-2014.
Amin RW; Stafford B; Guttmann RP
Sci Total Environ; 2019 Jun; 670():806-813. PubMed ID: 30921714
[TBL] [Abstract][Full Text] [Related]
2. Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic.
Baris D; Waddell R; Beane Freeman LE; Schwenn M; Colt JS; Ayotte JD; Ward MH; Nuckols J; Schned A; Jackson B; Clerkin C; Rothman N; Moore LE; Taylor A; Robinson G; Hosain GM; Armenti KR; McCoy R; Samanic C; Hoover RN; Fraumeni JF; Johnson A; Karagas MR; Silverman DT
J Natl Cancer Inst; 2016 Sep; 108(9):. PubMed ID: 27140955
[TBL] [Abstract][Full Text] [Related]
3. Bladder Cancer Mortality in the United States: A Geographic and Temporal Analysis of Socioeconomic and Environmental Factors.
Smith ND; Prasad SM; Patel AR; Weiner AB; Pariser JJ; Razmaria A; Maene C; Schuble T; Pierce B; Steinberg GD
J Urol; 2016 Feb; 195(2):290-6. PubMed ID: 26235377
[TBL] [Abstract][Full Text] [Related]
4. Relationships between arsenic concentrations in drinking water and lung and bladder cancer incidence in U.S. counties.
Mendez WM; Eftim S; Cohen J; Warren I; Cowden J; Lee JS; Sams R
J Expo Sci Environ Epidemiol; 2017 May; 27(3):235-243. PubMed ID: 27901016
[TBL] [Abstract][Full Text] [Related]
5. Patterns of ovarian cancer and uterine cancer mortality and incidence in the contiguous USA.
Amin RW; Ross AM; Lee J; Guy J; Stafford B
Sci Total Environ; 2019 Dec; 697():134128. PubMed ID: 31479898
[TBL] [Abstract][Full Text] [Related]
6. Bladder cancer and arsenic through drinking water: a systematic review of epidemiologic evidence.
Christoforidou EP; Riza E; Kales SN; Hadjistavrou K; Stoltidi M; Kastania AN; Linos A
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2013; 48(14):1764-75. PubMed ID: 24007431
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of lung and bladder cancer risk and oral exposure to inorganic arsenic: Meta-regression analyses of epidemiological data.
Lynch HN; Zu K; Kennedy EM; Lam T; Liu X; Pizzurro DM; Loftus CT; Rhomberg LR
Environ Int; 2017 Sep; 106():178-206. PubMed ID: 28625818
[TBL] [Abstract][Full Text] [Related]
8. Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 u.s.counties and 30 years of observation.
Taeger D; Pesch B
J Occup Environ Med; 2004 Oct; 46(10):1007-8; author reply 1009. PubMed ID: 15602170
[No Abstract] [Full Text] [Related]
9. Arsenic exposure predicts bladder cancer survival in a US population.
Kwong RC; Karagas MR; Kelsey KT; Mason RA; Tanyos SA; Schned AR; Marsit CJ; Andrew AS
World J Urol; 2010 Aug; 28(4):487-92. PubMed ID: 19834714
[TBL] [Abstract][Full Text] [Related]
10. Long-term impact of arsenic in drinking water on bladder cancer health care and mortality rates 20 years after end of exposure.
Fernández MI; López JF; Vivaldi B; Coz F
J Urol; 2012 Mar; 187(3):856-61. PubMed ID: 22248521
[TBL] [Abstract][Full Text] [Related]
11. Spatial Clusters of Breast Cancer Mortality and Incidence in the Contiguous USA: 2000-2014.
Amin RW; Fritsch BA; Retzloff JE
J Gen Intern Med; 2019 Mar; 34(3):412-419. PubMed ID: 30652275
[TBL] [Abstract][Full Text] [Related]
12. A spatial study of oral & pharynx cancer mortality and incidence in the U.S.A.: 2000-2015.
Amin RW; Rivera B
Sci Total Environ; 2020 Apr; 713():136688. PubMed ID: 32019034
[TBL] [Abstract][Full Text] [Related]
13. Arsenic Levels in Drinking Water Linked to Bladder Cancer in New England.
Zolot J
Am J Nurs; 2016 Aug; 116(8):16. PubMed ID: 27466910
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the association between bladder carcinoma and arsenic concentration in soil and water in southeast Brazil.
Cha JD; Lourenço DB; Korkes F
Int Braz J Urol; 2018; 44(5):906-913. PubMed ID: 30044600
[TBL] [Abstract][Full Text] [Related]
15. Arsenic and skin cancer in the USA: the current evidence regarding arsenic-contaminated drinking water.
Mayer JE; Goldman RH
Int J Dermatol; 2016 Nov; 55(11):e585-e591. PubMed ID: 27420023
[TBL] [Abstract][Full Text] [Related]
16. Estimating the risk of bladder and kidney cancer from exposure to low-levels of arsenic in drinking water, Nova Scotia, Canada.
Saint-Jacques N; Brown P; Nauta L; Boxall J; Parker L; Dummer TJB
Environ Int; 2018 Jan; 110():95-104. PubMed ID: 29089168
[TBL] [Abstract][Full Text] [Related]
17. Arsenic Exposure From Drinking Water and the Incidence of CKD in Low to Moderate Exposed Areas of Taiwan: A 14-Year Prospective Study.
Hsu LI; Hsieh FI; Wang YH; Lai TS; Wu MM; Chen CJ; Chiou HY; Hsu KH
Am J Kidney Dis; 2017 Dec; 70(6):787-797. PubMed ID: 28844585
[TBL] [Abstract][Full Text] [Related]
18. Bladder cancer and arsenic exposure: differences in the two populations enrolled in a study in southwest Taiwan.
Lamm SH; Byrd DM; Kruse MB; Feinleib M; Lai SH
Biomed Environ Sci; 2003 Dec; 16(4):355-68. PubMed ID: 15011967
[TBL] [Abstract][Full Text] [Related]
19. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water.
Marshall G; Ferreccio C; Yuan Y; Bates MN; Steinmaus C; Selvin S; Liaw J; Smith AH
J Natl Cancer Inst; 2007 Jun; 99(12):920-8. PubMed ID: 17565158
[TBL] [Abstract][Full Text] [Related]
20. Arsenic exposure in US public and domestic drinking water supplies: a comparative risk assessment.
Kumar A; Adak P; Gurian PL; Lockwood JR
J Expo Sci Environ Epidemiol; 2010 May; 20(3):245-54. PubMed ID: 19401722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
